U.S. Healthtech Stock News

McKesson Corporation recently reported its fourth-quarter and fiscal 2026 results, with quarterly sales of US$96,295 million and net income of US$1,682 million, alongside full-year sales of US$403.43 billion and net income of US$4.76 billion, while continuing sizable share repurchases under its long-running buyback program. Beyond the headline numbers, McKesson is preparing to separate its Medical-Surgical Solutions segment and is bolstering capital returns, moves that could reshape how...

AtriCure, Inc. has reported first-quarter 2026 results, with revenue of US$141.25 million up from US$123.62 million a year earlier and net income of US$0.108 million versus a net loss of US$6.75 million, marking a return to profitability. Management’s outlook for double-digit revenue expansion supported by recent product launches, including cryoSPHERE MAX and cryoXT, and growing adoption of the EnCompass and AtriClip platforms highlights how new devices and clinical investments are...

Understanding the recent move in HA Sustainable Infrastructure Capital stock HA Sustainable Infrastructure Capital (HASI) has drawn fresh interest after changing its name from Hannon Armstrong Sustainable Infrastructure Capital in June 2024. This has prompted investors to reassess what drives the stock and its fundamentals. See our latest analysis for HA Sustainable Infrastructure Capital. HASI’s share price has pulled back 0.8% over the past day and 6.2% over the past week, following a 27.7%...

Nextpower (NXT) has wrapped up FY 2026 with fourth quarter revenue of US$880.5 million and basic EPS of US$1.01, against trailing twelve month totals of US$3.6 billion in revenue and EPS of US$3.96, alongside EPS growth of 15.1% over the year. Over the past six quarters, the company has seen quarterly revenue move between US$679.4 million and US$924.3 million while quarterly EPS has ranged from US$0.80 to US$1.06, giving you a clear line of sight on how the current print sits within its...

Estée Lauder Companies (EL) is back in focus after fiscal third quarter results exceeded analyst expectations. Earnings per share came in well above forecasts, and fragrance revenue grew at a double digit rate. See our latest analysis for Estée Lauder Companies. Despite the recent earnings beat and raised full year outlook, the stock has been under pressure. The share price is down 23.1% year to date and the 3 year total shareholder return has declined 56.0%, while the 1 year total...

In recent months, Intuitive Surgical has faced FDA Class I recalls on certain da Vinci stapler components and visible institutional selling, raising concerns about product safety, regulatory scrutiny, and the resilience of its surgical robotics franchise. These events contrast with the company’s ongoing growth in da Vinci system installations and procedure volumes, sharpening the tension between operational momentum and rising risk perceptions among large investors. We’ll now explore how...

QXO (QXO) opened Q1 2026 with total revenue of US$1.7 billion and a basic EPS loss of US$0.31, as net income excluding extra items came in at a loss of US$227.1 million. Over the last five reported quarters, the company has seen revenue move from US$13.5 million in Q1 2025 to US$2.2 billion in Q4 2025 and then to US$1.7 billion in Q1 2026, while quarterly EPS moved from a loss of US$0.03 to a loss of US$0.17 and then to a loss of US$0.31 over the same stretch. For investors, the key focus...

In recent days, Texas Attorney General Ken Paxton filed a lawsuit accusing Netflix of illegally collecting and monetizing sensitive user and children’s data without proper consent and of designing its platform to be addictive. The state is seeking civil penalties, data deletion, and limits on targeted advertising, while Netflix calls the claims meritless and says it complies with privacy laws. The suit directly challenges Netflix’s data practices just as it leans more heavily on targeted...

Duke Energy (DUK) is back in focus after a busy start to May, with Q1 2026 results beating Wall Street expectations, dividends reaffirmed, and fresh financing plans tied to a larger multi year grid investment program. See our latest analysis for Duke Energy. Despite a busy stretch of earnings, capital plan updates and dividend declarations, Duke Energy’s share price has eased in the short term, with the 1 month share price return down about 5%. The 1 year total shareholder return of roughly...

Oculis Holding (NasdaqGM:OCS) has hit several key clinical milestones, including FDA Special Protocol Assessment agreement for its PIONEER-1 Phase 3 trial of Privosegtor in optic neuritis and completion of critical DIAMOND Phase 3 visits for OCS-01. See our latest analysis for Oculis Holding. Oculis Holding’s recent FDA SPA agreement for PIONEER-1 and progress in its DIAMOND Phase 3 program have come alongside a 56.85% year to date share price return and an 81.54% 1 year total shareholder...

General Dynamics' GDIT unit has formed a partnership with cybersecurity investment firm NightDragon. The collaboration focuses on bringing commercial artificial intelligence, cybersecurity, and autonomy tools into U.S. government programs. The agreement is intended to speed up government access to emerging security technologies through GDIT's federal customer base. General Dynamics (NYSE:GD) is moving to deepen its role in government technology integration with this GDIT NightDragon...

Electromed (ELMD) just posted Q3 2026 results with revenue of US$18.6 million and basic EPS of US$0.37, alongside trailing twelve month revenue of US$71.8 million and EPS of US$1.22 that sit against a 41.1% earnings growth rate over the past year. Over recent quarters the company has seen revenue move from US$15.7 million and EPS of US$0.22 in Q3 2025 to US$18.6 million and EPS of US$0.37 in Q3 2026, with trailing net profit margin at 14.1% compared with 11.7% a year earlier. This frames a...

Linde plc reported past first-quarter 2026 results with sales of US$8,781 million and net income of US$1,857 million, lifting basic earnings per share from continuing operations to US$4.00. The company also raised its full-year 2026 adjusted EPS guidance while returning over US$1.50 billion to shareholders, underlining management’s confidence and cash generation capacity. Next, we’ll examine how this upgraded earnings guidance and strong cash returns may influence Linde’s investment...

If you are wondering whether Barrick Mining's current share price offers genuine value or just reflects excitement, the recent performance gives you plenty to think about. The stock recently closed at US$44.87, with returns of 7.9% over 7 days, 4.3% over 30 days, 1.8% year to date, 160.6% over 1 year, 161.2% over 3 years and 111.2% over 5 years. Recent coverage around Barrick Mining has focused on its position in the global materials sector and how investors are reacting to that exposure...

Iron Mountain’s recent performance and what it means for investors Iron Mountain (IRM) has attracted fresh attention after a strong run in the stock, with the share price at US$126.12 and total return figures that stand out over the past year and multi year periods. For context, the stock is up over the past month and past 3 months, and its year to date and 1 year total returns are also positive. That kind of momentum often prompts investors to ask whether the current valuation still aligns...

Analog Devices (ADI) has moved into focus after a series of analyst upgrades linked to demand in AI hardware, industrial automation, and data center infrastructure ahead of its upcoming earnings announcement. See our latest analysis for Analog Devices. The stock’s recent move reflects that momentum has been strong for a while, with a 30 day share price return of 23.54% and a year to date share price return of 57.96%, alongside a 1 year total shareholder return of 93.54% and 5 year total...

How Amneal Pharmaceuticals Stock Has Been Trading Recently Amneal Pharmaceuticals (AMRX) has been on many investors' radars after a period of mixed share performance, with the stock down over the past week, month, and past 3 months despite a strong 1 year total return. See our latest analysis for Amneal Pharmaceuticals. Recent trading has been choppy, with the share price down over the past week and quarter, yet the 1 year and multi year total shareholder returns remain strong. This suggests...

Diodes Incorporated (NasdaqGS:DIOD) announced the retirement of longtime Chairman Dr. Keh-Shew Lu after more than 25 years with the company. The board elected Angie Chen Button as the new Chairwoman of the Board, marking a significant leadership change at Diodes. This transition closes a chapter in which Diodes evolved from a mid-sized business into a global semiconductor company. Diodes focuses on semiconductor products that sit behind many everyday electronics, with exposure to...

GitLab (NasdaqGS:GTLB) has announced a major global restructuring and workforce reduction aimed at repositioning the company for what it calls the agentic AI era. The plan includes country exits, a flatter management structure, and a shift to smaller autonomous teams focused on AI driven software development. GitLab intends to reinvest cost savings from the restructuring into AI infrastructure and an AI centric engineering operating model referred to internally as Act 2. The company has...

If you are wondering whether Dana's share price still offers value after a strong run, it helps to step back and look at what the current market price might be implying about the business. The stock has pulled back over the last week and month, declining 3.7% over 7 days and 6.5% over 30 days, yet it is still up 37.4% year to date and 108.2% over the past year. Recent coverage around Dana has focused on its role in the Auto Components sector and how investors are reacting to that...

JPMorgan Chase stock in focus JPMorgan Chase (JPM) is back on investors’ radar after recent share price weakness, with the stock down 4.3% over the past month and 0.8% over the past 3 months from its last close of US$300.25. See our latest analysis for JPMorgan Chase. Recent share price momentum has cooled, with the stock down 7.8% year to date, even though the 1 year total shareholder return of 15.2% and very large 3 year total shareholder return of about 13x point to a stronger longer...

For readers wondering whether Fair Isaac, at around US$1,064 per share, is now a bargain or still richly priced, this article walks through what the numbers indicate about the stock's value. The share price has been relatively flat over the last 7 days, edging down 0.2%. It has risen 6.4% over the past month while still sitting well below its levels from earlier in the year, with the stock down 35.2% year to date and 49.9% over the last 12 months. These moves come as investors reassess Fair...

In early May 2026, Tempus AI completed a US$400 million zero-coupon, senior unsecured convertible note offering due 2032 under Rule 144A, shortly after reporting first-quarter revenue of US$348.12 million and a wider net loss of US$125.92 million alongside higher full-year 2026 guidance. At the same time, the company deepened its role in precision medicine through a Lucent Diagnostics collaboration on Alzheimer’s blood-based biomarkers and industry recognition for Ambry Genetics’ CARE...

Mercury Systems (MRCY) has drawn fresh attention after reporting third quarter and nine month results to March 27, 2026, with higher sales and a sharply reduced net loss compared with a year earlier. See our latest analysis for Mercury Systems. The latest results appear to have reinforced a recovery story in the stock, with a 30 day share price return of 12.09% and a 1 year total shareholder return of 106.11%, suggesting momentum has been building over time. If these results have you looking...